Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals Q2 FY27: Net Profit Rs. 11.53 Lakhs, Revenue Rs. 166.87 Lakhs
RESULTS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 14 Nov 2026, 06:55 PM IST · BSE ID: 3c53c23c-e1ab-426a-b35a-881393e673c9
View Original BSE Filing (PDF)
💡
In Simple Terms
Biofil Chemicals reported a net profit of Rs. 11.53 Lakhs and revenue of Rs. 166.87 Lakhs for the July-September 2026 quarter.
🤖 AI Summary
- Biofil Chemicals reported a Net Profit of Rs. 11.53 Lakhs for Q2 FY27.
- Revenue from Operations for the quarter ended September 30, 2026, was Rs. 166.87 Lakhs.
- Total Income for Q2 FY27 stood at Rs. 179.92 Lakhs.
- Basic Earnings Per Share was Rs. 0.07 for the quarter ended September 30, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from Operation Q2 FY27
166.87 Lakhs
Not comparable — limited prior period data.
Net Profit Q2 FY27
11.53 Lakhs
Not comparable — limited prior period data.
Total Income Q2 FY27
179.92 Lakhs
Not comparable — limited prior period data.
Basic EPS Q2 FY27
0.07 Rs
Not comparable — limited prior period data.
Half Year Revenue from Operation FY27
1401.89 Lakhs
Not comparable — limited prior period data.
Half Year Net Profit FY27
22.44 Lakhs
Not comparable — limited prior period data.
🏢 How This Affects the Company
The company recorded a Net Profit of Rs. 11.53 Lakhs for Q2 FY27, contributing to a half-year Net Profit of Rs. 22.44 Lakhs. Revenue from Operations for the half-year reached Rs. 1401.89 Lakhs.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance. The Basic Earnings Per Share for continuing operations was Rs. 0.07 for Q2 FY27.
🔍
Management Signal
The approval and disclosure of unaudited financial results indicate management's adherence to regulatory compliance and periodic performance reporting.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Q3 FY27 results — review trends in revenue and profitability.
Annual General Meeting details — check for future strategic announcements.
XBRL filing submission — verify complete financial details.
MEDIUM RISK
Significant fluctuations in revenue and purchases of stock-in-trade between quarters and half-year periods.
💡 Investor Takeaway
Biofil Chemicals & Pharmaceuticals Ltd reported Q2 FY27 Net Profit of Rs. 11.53 Lakhs, up from Rs. 8.36 Lakhs in Q2 FY26. Revenue from Operations was Rs. 166.87 Lakhs in Q2 FY27, compared to Rs. 1354.08 Lakhs in the prior year's comparable quarter.
⚖️ Strengths & Concerns
✅ Positives
- Net Profit for Q2 FY27 increased to Rs. 11.53 Lakhs from Rs. 8.36 Lakhs in Q2 FY26.
- Revenue from Operations for Q2 FY27 was Rs. 166.87 Lakhs, compared to Rs. 1354.08 Lakhs in Q2 FY26.
⚠️ Concerns
- Cost of materials consumed significantly increased to Rs. 128.55 Lakhs in Q2 FY27 from Rs. 118.19 Lakhs in Q2 FY26.
- Purchases of stock-in-trade were zero in Q2 FY27, a decrease from Rs. 707.46 Lakhs in Q2 FY26.
📅 Company Track Record
No previous filings found for Biofil Chemicals & Pharmaceuticals Ltd to establish a historical context beyond the current and prior year results provided in this filing.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Biofil Chemicals & Pharmaceuticals Ltd's Net Profit for Q2 FY27?
Biofil Chemicals & Pharmaceuticals Ltd reported a Net Profit of Rs. 11.53 Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What was the Revenue from Operations for Biofil Chemicals in Q2 FY27?
The Revenue from Operations for Biofil Chemicals & Pharmaceuticals Ltd in Q2 FY27 was Rs. 166.87 Lakhs.
What was the Basic Earnings Per Share (EPS) for Biofil Chemicals in Q2 FY27?
The Basic Earnings Per Share (EPS) for Biofil Chemicals & Pharmaceuticals Ltd was Rs. 0.07 for the quarter ended September 30, 2026.
What is the half-year Net Profit for Biofil Chemicals & Pharmaceuticals Ltd for FY27?
For the half-year ended September 30, 2026, Biofil Chemicals & Pharmaceuticals Ltd reported a Net Profit of Rs. 22.44 Lakhs.
Questions based on this BSE filing only. For information purposes.